ACCURATE TEST. FAST RESULTS.

We perform medical diagnostic tests and efficiently provide accurate results that help your physician screen for, diagnose, and manage the treatment of health problems.

LABORATORY TEST DIRECTORY

SEARCH

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance by Next Generation Sequencing

CPT Code(s): 81170
Specimen Required: Patient Preparation:
Collect:Lavendar (EDTA) or bone marrow (EDTA).
Specimen Preparation:Transport 5 mL whole blood or 3 mL bone marrow. (Min: 1 mL)
Storage/Transport Temperature:Refrigerated.
Stability:Ambient: 1 hour; Refrigerated: 48 hours; Frozen: Unacceptable
New York DOH Approval Status: This test is New York DOH approved.
Aliases:
  • ABL Mutation (BCR-ABL1 Kinase Domain Mutation Analysis)
  • ABL1 Mutation Analysis for Imatinib (BCR-ABL1 Kinase Domain Mutation Analysis)
  • BCR-ABL1 Domain Mutation Analysis
  • BCR-ABL1 Mutation (BCR-ABL1 Domain Mutation Analysis)
  • Gleevec Resistance Mutation Analysis (BCR-ABL1 Kinase Domain Mutation Analysis)
  • Imatinib Mesylate Resistance Analysis (BCR-ABL1 Kinase Domain Mutation)
  • Imatinib Resistance Analysis (BCR-ABL1 Kinase Domain Mutation Analysis)
  • TKI Therapy Resistance
    		•